Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Technology Stocks : TAVA Technologies (TAVA-NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: C.K. Houston who wrote (14968)	4/17/1998 11:39:00 AM
From: Mighty_Mezz	Read Replies (2) \| Respond to of 31646

Before the bell, news was on PR newswire. 5 minutes ago story hit Business Wire - just the CMED part. Colorado MEDtech Inc. and TAVA Technologies Inc. Announce Licensing Agreement Business Wire - April 17, 1998 11:33 %COLORADO-MEDTECH %TAVA CMED TAVA %COLORADO %MEDICINE %BIOTECHNOLOGY %COMPUTERS %ELECTRONICS %COMED V%BW P%BW BOULDER, Colo.--(BW HealthWire)--April 17, 1998--Colorado MEDtech Inc. (NASDAQ: CMED) today announced the signing of a licensing agreement with TAVA Technologies Inc. (NASDAQ: TAVA) for TAVA's Plant Y2kOne(TM) products for year 2000 compliance of biomedical devices used in hospitals, clinics and extended care facilities. CMED will modify the Plant Y2kOne(TM) software tool and database structure, as appropriate, to tailor it specifically to the needs of the health care market. The modified system will be called BioMed Y2kOne(TM). CMED will offer a combination of tools and services to support health care institutions' efforts to establish year 2000 compliance for their biomedical devices. CMED will work directly with clients in cooperation with information technology service companies that are providing year 2000 compliance services in the health care industry. CMED will also market TAVA's Plant Y2kOne(TM) product to hospitals, clinics and extended care facilities to address year 2000 compliance of embedded systems in building operations systems such as HVAC controls, boilers and sprinkler systems. John Jenkins, TAVA's chief executive officer, said: "We believe that the market for year 2000 compliance tools and services in the health care industry is significant. Health care providers need to be concerned about the compliance status of their medical devices and their facility support systems. While Plant Y2kOne(TM) will address the facility support systems, TAVA does not have the expertise required to address medical device issues. Colorado MEDtech brings that element to the table." John Atanasoff, Colorado MEDtech's president and chief executive officer, commented, "We believe that, with our strong medical device background and the BioMed Y2kOne(TM) system and database, we will be able to offer unique services to the health care industry." Atanasoff also added that the company already has secured one engagement to provide year 2000 compliance support for a large hospital chain. TAVA Technologies Inc., based in Englewood, Colo., is a leading provider of automation and information technology solutions to industry. Colorado MEDtech Inc., through its wholly owned affiliates and operating divisions, is a leading full-service provider of advanced medical products and comprehensive outsourcing services. CONTACT: Colorado MEDtech Inc. John V. Atanasoff or Bruce L. Arfmann, Phone: 303/530-2660 Fax: 303/581-1010 E-mail: cmedinfo@cmed.com Website: www.cmed.com or TAVA Technologies Inc. John Jenkins Phone: 303/771-9794 or Pacific Consulting Group Inc. Scott Liolios Phone: 714/574-3860

To: C.K. Houston who wrote (14968)	4/17/1998 5:13:00 PM
From: C.K. Houston	Read Replies (4) \| Respond to of 31646

In spite of all this whining about PR, *this chart looks dmn good to me! Volatility before warrant conversion was expected. iqc.com Once we have full NMS listing, I imagine PR releases will be handled differently. I view this conservative approach to PR releases as smart, at this point in time. I want NMS listing. Anything that could be construed as "hype" by the company, to manipulate stock price could kill this. Management understands this. Fortunately Jenkins has a law background, in addition to engineering.** Both requiring logic and analysis. He and his management team have a better grasp of what's going on "behind the scenes" than any poster on this thread. While everyone's been nit-picking about PR and watching ticks today, I've been revising my 53 page Medical Report for Healthcare Professionals to include today's news. Why? Because I got an email this morning from the UK Y2K manager from a MAJOR pharmaceutical company (listed below), requesting my report. TAVA Pharmaceutical Clients Core Business: - Abbott Laboratories - Baxter - DuPont-Merck - Eli-Lilly - Genentech Inc - Glaxo-Wellcome - Hoffman-LaRoche - Merck & Co - Pfizer - Wyeth Ayerst TAVA Pharmaceutical Clients Year 2000 Assessment & Remediation: - Bristol-Meyers Squibb - 125 sites worldwide I won't identify who it is. It's not Bristol-Meyers Squibb. So don't bother trying to guess. Here's the email: "My name is XXXX XXXXX and I am a Year 2000 project manager within the UK part of XXXXXX. There is not much information around on medical devices, and embedded systems will form a large part of my project. Could you please mail me a copy of your Medical Report?" The embedded system problem within medical devices is a SERIOUS issue. The lack of available information out there is appalling. This will be a REAL money-maker for TAVA and CMED. Will take a few months to see impact on revenues. But when you do ... watch out!! *You may have noticed, that many of the people who contributed in-depth ... don't anymore.* It's because of all of this trading chat and small talk on THIS thread. I will soon be one of them - unless some of this small talk goes to the "TAVA Trading" thread. Fine with me, because what I do takes a LOT of time. Subject 16061 Cheryl

To: C.K. Houston who wrote (14968)	5/5/1998 5:40:00 PM
From: C.K. Houston	Read Replies (2) \| Respond to of 31646

TAVA, RW BECK & RICK COWLES =============================================================== Soon we'll see more mainstream articles like this, where Rick Cowles, our new TAVA\|R.W. Beck Director of Sales, will be quoted. This was probably his last quoted article as DEC, Y2K Utility Project Manager. YEAR 2000 BUG COULD BRING CHILLS TO UTILITY USERS "It doesn't take more than one or two small power companies having significant problems before you will have problems across the entire grid," said Cowles, a 17-year veteran managing information systems in electric utilities. [There's more ... read link] nj.com Here's Rick's "Y2K Electricity Utility Site": epriweb.com Sure like the people who are linked to Rick's site: Message 4320370 Go to C.K. HOUSTON's TAVA Research Report to find out about R.W. Beck & TAVA. Message 3853836 TAVA\|R.W. BECK is a separate company owned 50/50 by TAVA & R.W. Beck - Learned that at NYC Conference. Don't know full details, so don't ask me for more info. RW BECK rwbeck.com Cheryl